收藏切换
Metabolomics-based analysis of the interventional effects of peroxydehydrotumulosic acid in Poria cocos on airway inflammation in asthma
收藏切换
Qi-mei TIE1, 2, Meng-nan ZENG1, 2, Bei-bei ZHANG1, 2, Yan-ling CHEN1, 2, Chao-yuan XIAO1, 2, Lin CHEN1, 2, Ke-rui KANG1, Jia-yin JIN1, Wei-sheng FENG1, 2, 3, Xiao-ke ZHENG1, 2, 3, *
Acta Pharmaceutica Sinica | 2026, 61(1) : 222 - 232
Less
收藏切换
Acta Pharmaceutica Sinica | 2026, 61(1): 222-232
• Original Articles •
Metabolomics-based analysis of the interventional effects of peroxydehydrotumulosic acid in Poria cocos on airway inflammation in asthma
Full
Qi-mei TIE1, 2, Meng-nan ZENG1, 2, Bei-bei ZHANG1, 2, Yan-ling CHEN1, 2, Chao-yuan XIAO1, 2, Lin CHEN1, 2, Ke-rui KANG1, Jia-yin JIN1, Wei-sheng FENG1, 2, 3, Xiao-ke ZHENG1, 2, 3, *
Affiliations
  • 1Henan University of Traditional Chinese Medicine, Zhengzhou 450046, China
  • 2Henan Engineering Research Center for Traditional Chinese Medicine Development, Zhengzhou 450046, China
  • 3Provincial-Ministerial Collaborative Innovation Center for Prevention and Treatment of Respiratory Diseases in Traditional Chinese Medicine, Henan University of Traditional Chinese Medicine, Zhengzhou 450046, China
Published: 2026-01-12 doi: 10.16438/j.0513-4870.2025-0560
Outline
收藏切换

The study aims to investigate the interventional effect of peroxydehydrotumulosic acid (PHA) in Poria cocos on allergic asthma mice, and to investigate its mechanism of action based on metabolomics. Male BALB/c mice were randomly divided into normal group (CON), model group (M), positive drug montelukastna group (Y, 1.3 mg·kg-1), PHA low-dose group (PHA-L, 15 mg·kg-1), and PHA high-dose group (PHA-H, 30 mg·kg-1). The mouse model of allergic asthma was established by intraperitoneal injection of ovalbumin (OVA) and aluminium hydroxide adjuvant for sensitisation and OVA nebulisation for excitation. The corresponding drugs were given by gavage 30 min before modelling, and the drugs were administered for 7 consecutive days. 24 h after the last administration of the drugs, the mice were tested for cough and asthma indexes, lung function and lung coefficient, the mice were stained with hematoxylin-eosin (HE) to observe the pathological changes of the lung histology, and the mice were stained with Masson to observe the level of collagen fibre deposition, and the levels of inflammatory factors in the serum and alveolar lavage fluid of the mice were measured by enzyme-linked immunosorbent assay (ELISA) and flow cytometry to determine the levels of inflammatory factors in the mice. Apoptotic cell levels in lung tissue and Th17 and Tregs cell levels in blood were detected by flow cytometry, and small molecule metabolites were analysed by liquid-liquid mass spectrometry (LC-MS) in serum samples of mice of different treatment groups. The metabolic pathway enrichment analysis was used to investigate the biometabolic pathways involved in the characterised metabolites. The results indicated a comparison with group M, PHA significantly improved lung function, reduced lung coefficient, attenuated lung histopathological damage and collagen fibre deposition, significantly down-regulated the levels of interleukin 4 (IL4), immunoglobulin E (IgE), interleukin 17A (IL17A) in blood and tumor necrosis factor-α (TNF-α) in alveolar lavage fluid, inhibited apoptosis and the generation of Th17 cells, and increased the level of Tregs cells in lung tissue. Metabolomics analysis of endogenous substances in the M and PHA groups separated significantly, and 63 differential metabolites were screened, mainly involving arachidonic acid metabolism, retinol metabolism, biosynthesis of phenylalanine, tryptophan, and tyrosine, glycerophospholipid metabolism, and tyrosine metabolism. PHA can improve the pathological state of mice with asthma by inhibiting the production of inflammatory factors IL4 and IL17A, hindering the recruitment of inflammatory cells, and regulating some differential metabolites and metabolic pathway disorders. The animal experiment was approved and supervised by the Animal Ethics Committee of Henan University of Traditional Chinese Medicine (ethics number: DWLL2018080003).

peroxydehydrotumulosic acid  /  asthma  /  metabolomics  /  airway inflammation
铁玘美, 曾梦楠, 张贝贝, 陈艳玲, 肖超远, 陈霖, 康珂瑞, 靳佳音, 冯卫生, 郑晓珂. 基于代谢组学分析茯苓中过氧去氢土莫酸对哮喘气道炎症的干预作用. 药学学报, 2026 , 61 (1) : 222 -232 . DOI: 10.16438/j.0513-4870.2025-0560
Qi-mei TIE, Meng-nan ZENG, Bei-bei ZHANG, Yan-ling CHEN, Chao-yuan XIAO, Lin CHEN, Ke-rui KANG, Jia-yin JIN, Wei-sheng FENG, Xiao-ke ZHENG. Metabolomics-based analysis of the interventional effects of peroxydehydrotumulosic acid in Poria cocos on airway inflammation in asthma[J]. Acta Pharmaceutica Sinica, 2026 , 61 (1) : 222 -232 . DOI: 10.16438/j.0513-4870.2025-0560
Year 2026 volume 61 Issue 1
193
106
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2025-0560
  • Receive Date:2025-05-16
  • Online Date:2026-09-21
  • Published:2026-01-12
Article Data
Affiliations
History
  • Received:2025-05-16
  • Revised:2025-09-17
Affiliations
    1Henan University of Traditional Chinese Medicine, Zhengzhou 450046, China
    2Henan Engineering Research Center for Traditional Chinese Medicine Development, Zhengzhou 450046, China
    3Provincial-Ministerial Collaborative Innovation Center for Prevention and Treatment of Respiratory Diseases in Traditional Chinese Medicine, Henan University of Traditional Chinese Medicine, Zhengzhou 450046, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2025-0560
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT